GlassScriptPhysician profile
Doris A Kleinert
NPI 1861474751
$5,340.40
in general payments reported to CMS, 2019-2025
45 companies · $530 in 2025
The $530 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $758 · 2021: $1,001 · 2022: $720 · 2023: $864 · 2024: $919 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,314.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,074.65 | 2021-2025 | |
| Novo Nordisk INC | $602.12 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $506.40 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $414.17 | 2020-2025 | |
| Glaxosmithkline, LLC. | $308.31 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Allergan, INC. | $194.77 | 2019-2021 | |
| Lilly USA, LLC | $190.35 | 2020-2024 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $184.27 | 2019-2023 | Pneumovax 23, Vaxelis, Vaxneuvance |
| Esperion Therapeutics, INC. | $142.19 | 2020-2023 | Nexletol |
| Eisai INC. | $136.66 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $128.84 | 2022 | |
| Amgen INC. | $122.11 | 2019-2025 | Repatha, Otezla, Otezla |
| Astellas Pharma US INC | $108.54 | 2022-2025 | Veozah |
| Bausch Health US, LLC | $102.45 | 2020-2023 | Aplenzin |
| Sanofi Pasteur INC. | $101.23 | 2019-2023 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $95.02 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $78.51 | 2021 | |
| Genentech USA, INC. | $70.27 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.76 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.86 | 2020-2022 | |
| Cranial Technologies, INC | $53.83 | 2020-2025 | Doc Band |
| Exact Sciences Corporation | $49.98 | 2023-2024 | Cologuard Collection Kit |
| Shire North American Group INC | $48.00 | 2019 | |
| Optinose US, INC. | $41.75 | 2020-2021 | |
| Nevro Corp. | $38.35 | 2022-2023 | Senza |
| Daiichi Sankyo INC. | $35.58 | 2019-2020 | |
| Philips North America LLC | $35.11 | 2024 | (Ck7) Extended Holter |
| Xeris Pharmaceuticals, INC. | $34.42 | 2021-2023 | Keveyis |
| Exeltis, USA INC. | $32.09 | 2023-2024 | Slynd |
| Seqirus USA INC | $29.20 | 2024 | Fluad, Flucelvax |
| Edwards Lifesciences Corporation | $25.00 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Hologic Sales and Service, LLC | $23.70 | 2025 | Aptima, Thinprep 2000 Processor |
| Aimmune Therapeutics, INC. | $23.27 | 2025 | Zenpep |
| Biogen, INC. | $21.52 | 2021 | |
| Boston Scientific Corporation | $19.50 | 2023 | |
| Organon LLC | $18.95 | 2025 | Nexplanon |
| Neos Therapeutics, LP | $17.54 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.44 | 2023 | Nuzyra |
| Tactile Systems Technology INC | $16.35 | 2020 | |
| Inogen, INC. | $15.62 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Idorsia Pharmaceuticals US INC | $14.97 | 2023 | Quviviq |
| Lucid Diagnostics INC. | $14.77 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.58 | 2021 | |
| Medtronic, INC. | $13.87 | 2025 | Inceptiv |
| Ironshore Pharmaceuticals INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Kleinert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.